Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Investor supports Sobi’s tender offer for CTI BioPharma and undertakes to subscribe for its pro rata share in Sobi’s rights issue

Sobi has today communicated its offer to acquire CTI BioPharma (CTI), a US listed company within hematology, for USD 9.10 per share, equivalent to an enterprise value of USD 1.7bn and to carry out a rights issue with preferential rights for existing shareholders to partially finance the acquisition. Investor AB, Sobi’s largest owner, with an ownership of 34.7 per cent of the capital and votes, supports the bid and has undertaken to subscribe for its pro rata share in the rights issue corresponding to SEK 2.9bn. “Investor was instrumental in the creation of Sobi close to 15 years ago.

Interim Report 3 months - 1 January-31 March 2023

FIRST QUARTER (1 JAN-31 MAR 2023) · Net sales declined by 12 percent to MSEK 1,505 (1,716), of which currency-adjusted sales declined 15 percent. · Operating profit before depreciation and amortisation (EBITDA) excluding non-recurring items of MSEK 0 (-11) amounted to MSEK 138 (168) 1). · Operating profit amounted to MSEK 70 (86) 1), corresponding to an operating margin of 4.7 percent (5.0). · Profit after financial items totalled MSEK 57 (80). · Profit after tax amounted to MSEK 41 (57). · Earnings per share before and after dilution totalled SEK 0.15 (0.25). 2) ·

Camurus’ Interim Report January-March 2023

“A strong quarter with solid organic growth, both top and bottom line” Summary first quarter 2023 January – March · Total revenues amounted to SEK 284 (220) million, an increase of 29% (24% at CER[1]), whereof product sales were SEK 282 (202) million, an increase of 40% (35% at CER[1]) · Revenue and product sales increased 6% compared to previous quarter · Operating result was SEK 74 (5) million, an increase of SEK 69 million · Cash position at the end of the quarter was SEK 586 (400) million, an increase of SEK 186 million (47%) · Number of patients treated with

Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare haematology

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that it has entered into an agreement and plan of merger with CTI BioPharma Corp. (CTI) under which Sobi has agreed to acquire CTI, a biopharmaceutical company focused on blood related cancers and

Everfuel – Q1 2023: Strengthened European hydrogen position

Herning, 10 May 2023 – Everfuel A/S today published its first quarter 2023 financial results. Key events · Launch of JV with Hy24 for EUR 200 million of equity investment for accelerated development of green hydrogen infrastructure in the Nordics · Successfully completed EUR 25 million private placement · HySynergy Phase 1 progressing towards mechanical and electrical completion in late Q2 2023, ramp-up of commercial production subject to establishment of best-practice for safe and efficient operations, facility organisation and permitting · Signed agreement for the First

Multiconsult first quarter 2023 – best quarter ever

Multiconsult ASA (OSE: MULTI)The positive trend and strong market development continues, and Multiconsult delivered the best quarter ever. Multiconsult’s first quarter EBITA was NOK 216.3 million, a margin of 16.5 per cent. There was high activity in most segments, and the result was positively impacted by higher billing rates and increased capacity. Net operating revenues grew by 15.1 per cent year-on-year to NOK 1 310.2 million, while the organic growth was 12.1 per cent y-o-y. The result from the segment LINK Arkitektur has improved compared to the same quarter last year. For the second

ABS Explores Near-Shore Green Hydrogen Production in Korea

MOU Signed by ABS and Leading Industry Players (MUNICH) ABS joined Korean industry leaders in the signing of a memorandum of understanding (MOU) to produce a feasibility study for a near-shore floating platform of green hydrogen production and liquefaction. ABS joins the Korea Institute of Energy Technology (KENTECH); HD Korea Shipbuilding and Offshore Engineering (HD KSOE), part of HD Hyundai Group; Linde Korea; and Linde PLC in the MOU. The study is the latest in ABS’ pioneering work to support green hydrogen production, which includes an approval in principle (AIP) for HD

#23-159 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Nordea Bank Abp: Repurchase of own shares on 09.05.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares09.05.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 09.05.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |148,601|9.62 |1,428,932.

Salmon Evolution ASA: Cancellation of the potential subsequent offering

Reference is made to the stock exchange announcement published by Salmon Evolution ASA ("Company") on 19 April 2023 regarding the successful placing of a private placement of 68,181,818 shares at a subscription price of NOK 7.7 (the “Subscription Price”) in the Company to raise gross proceeds of NOK 525 million (the "Private Placement") and a potential subsequent share offering of up to 6,500,000 new shares at the Subscription Price (the "Subsequent Offering"). The Company expressed that any such potential Subsequent Offering was conditional on, inter alia, prevailing market price of the

Trading of own shares as part of employee's savings scheme

SpareBank 1 SR-Bank ASA has on 9 May 2023 purchased 25 334 own shares at an average price of 119.4546. Total holdings of own shares after the purchase is 123 435 shares. The shares were acquired as part of SpareBank 1 SR-Bank's savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 19 December 2022, and the stock exchange notice dated 14 April 2023.

Annual Report 2022

Scout Gaming’s annual accounts for financial year 2022 has today been published on the company’s website. https://www.scoutgaminggroup.com/investor-relations/financial-reports.  For additional information, please contact:Niklas Jönsson, CEOPhone: +46 725 494 173E-mail: niklas.jonsson@scoutgaminggroup.com Andreas Olsen, CFOPhone: +47 970 75 255E-mail: andreas.olsen@scoutgaminggroup.com About Scout Gaming GroupScout Gaming Group is a licensed and regulated provider of B2B Daily Fantasy Sports, Sportsbook, Fantasy betting and other sports betting products. The company

Communiqué from the Annual General Meeting and statutory meeting of the Board of Directors of Mycronic AB (publ)

The Annual General Meeting of Mycronic AB (publ) was held on May 9, 2023. The Annual General Meeting was carried out with the physical presence of shareholders and representatives. The shareholders were also allowed to exercise their voting rights prior to the general meeting by advance voting, so-called postal voting.   The following decisions were made at the Annual General Meeting.    Income statements and balance sheets The Annual General Meeting adopted the income statement and the balance sheet and the consolidated income statement and the consolidated balance sheet for

SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program

SmartCraft ASA | Acquisition or disposal of the issuer's own shares Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). From 25 April 2023 until 27 April 2023, under the last buy-back programme which ended 28 April 2023, SmartCraft has purchased a total of 39,145 own shares at an average price of NOK 19.8903 per share. Under the last buy-back programme, in the period 3 November 2022 to 27 April 2023, the Company purchased a total of 1,297,848 of its own shares at an average price of NOK 17.6339

Bulletin from Balco Group’s Annual General Meeting 2023

Annual General Meeting for Balco Group AB was held on Tuesday May 9 2023, at Kök 11, Honnörsgatan 15 in Växjö.The Annual General Meeting approved the groups income statements and balance sheets and discharged the members of the board and CEO from liability for the financial year of 2022. The Annual General Meeting resolved on a dividend of 1.50 SEK per share, corresponding to a total of 32,864,022 SEK, divided into two payments, 0.75 SEK per share in May 2023 and SEK 0.75 per share in November 2023. The Annual General Meeting approved the Board of Directors remuneration report for

ANNUAL GENERAL MEETING IN AB SAGAX

AB Sagax (publ) has held its Annual General Meeting on 9 May 2023.   Appropriation of retained earnings and discharge from liability   The Annual General Meeting adopted the income statement and the balance sheet as well as the Board of Directors’ proposal on appropriation of retained earnings. The Annual General Meeting also adopted the Board of Directors’ proposal for dividend to the shareholders of SEK 2.70 per ordinary share of series A and series B and on a dividend to the shareholders of SEK 2.00 per ordinary share of series D for the financial year 2022, with a quarterly

Gripen E production line inaugurated in Brazil

Saab and Embraer have today inaugurated the production line for Gripen E in Brazil, at Embraer´s plant in Gavião Peixoto (São Paulo State). This is an important milestone in the technology transfer programme and the companies' commitment to work together on new business opportunities.The event was attended by high-ranking civil and military authorities, as well as representatives from various sectors of Brazilian society. The President of Brazil, Luiz Inácio Lula da Silva, participated in the ceremony, together with the Minister of Defense, José Mucio Monteiro Filho and the Brazilian Air

2020 Bulkers Ltd. (2020) – 2023 Annual General Meeting

2020 Bulkers Ltd. (the “Company”) advises that the 2023 Annual General Meeting of the Company was held on Tuesday, May 9th, 2023 at 4:00 p.m. at the Company’s offices at Tjuvholmen Allé 3, 0252 Oslo, Norway.  The audited consolidated financial statements for the Company for the year ended December 31, 2022 were presented to the Meeting. The following resolutions were passed: 1. To set the maximum number of Directors to be not more than five. 2. To resolve that vacancies in the number of Directors be designated as casual vacancies and that the Board of Directors be authorized to

BerGenBio to hold business update conference call

- Management to provide clinical and financial updates, and outline proposed rights issue - - Webcast will take place on Monday, May 15, 2023, at 10 a.m. CEST -   BERGEN, Norway, May 9, 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that it will hold a business update conference call on Monday, May 15, 2023, at 10 a.m. CEST. BerGenBio’s senior management team will provide a briefing via a webcast presentation on the Company’s website, followed by a Q&A

Buy-back of shares in MTG during week 19, 2023

The 8[ ]of May 2023 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 230 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company.The share buy-backs form a part of the share repurchase program of a maximum of 4,618,818 shares for a maximum amount of SEK 400 million, which MTG announced on 25 October 2022. The share repurchase program, which runs from 27 October 2022 up and until the Annual General Meeting

Bulletin from the Annual General Meeting in Nexam Chemical Holding AB (publ) on May 9 2023

Today, on May 9 2023, the annual general meeting was held in Nexam Chemical Holding AB (publ). A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.Resolution on adoption of accounts and allocation of the company's result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The annual general meeting also resolved in accordance with the proposal from the Board to allocate the company's result, meaning that no dividends

#23-158 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

23-157 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Atria Plc: SHARE REPURCHASE 9.5.2023

Atria Plc  ANNOUNCEMENT  9.5.2023 Atria Plc: SHARE REPURCHASE 9.5.2023 In the Helsinki Stock Exchange Trade date           9.5.2023Bourse trade         BuyShare                  ATRAVAmount             3 900 SharesAverage price/ share    10,2400 EURTotal cost            39 936,00 EUR Atria Plc now holds a total of 72 302 sharesincluding the shares repurchased on 9.5.2023 On behalf of Atria Plc Nordea Bank Oyj Janne Sarvikivi           Sami Huttunen

There are no items matching the current filter
There are no more items matching the current filter
Back to top